Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-29 @ 11:49 AM
Study NCT ID:
NCT01307306
Status:
COMPLETED
Last Update Posted:
2022-03-28
First Post:
2011-01-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glucose Control in Severely Burned Patients
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Study Overview
Official Title:
Glucose Control in Severely Burned Patients: Mechanisms and Therapeutic Potential
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The central aim of this application is to determine whether improved outcomes with tight euglycemic control are due to insulin-specific responses. The investigators hypothesize that improving insulin resistance will lead to decreased inflammatory and hypermetabolic responses, as well as restored glucose metabolism, and so result in improved clinical outcome of severely burned patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: